Academic Journal
Q2Expert Review of Clinical Immunology
About Expert Review of Clinical Immunology
About Expert Review of Clinical Immunology
Expert Review of Clinical Immunology is a peer-reviewed scholarly journal published by Taylor and Francis Ltd. (United Kingdom). It focuses on Q2. Publication coverage spans 2006-2026.
Key indicators: ISSN 1744-666X, 1744-8409; H-index 85; Impact Factor 4.0.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (85): Strong citation impact — 85 articles cited at least 85 times each, reflecting solid influence.
- Impact Factor (4.0): Average citations per recent article. A solid figure indicating regular citation by the research community.
Publishing in Expert Review of Clinical Immunology
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q2. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Expert Review of Clinical Immunology?
1744-666X, 1744-8409.
Who publishes Expert Review of Clinical Immunology?
Taylor and Francis Ltd..
What are Expert Review of Clinical Immunology's metrics?
Impact Factor 4.0; H-index 85.
Where do I submit to Expert Review of Clinical Immunology?
Via the official website.
Is Expert Review of Clinical Immunology peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Verified field sources
- Journal Impact Factor: 4.0 — Official source; checked 2026-10-03. Publisher-reported Journal Impact Factor and year from Taylor & Francis About this journal information.
- Impact Factor year: 2025 — Official source; checked 2026-10-03. Publisher-reported Journal Impact Factor and year from Taylor & Francis About this journal information.
Source-backed journal facts
Topics in published research
Asthma and respiratory diseases; Systemic Lupus Erythematosus Research; Rheumatoid Arthritis Research and Therapies; Allergic Rhinitis and Sensitization; Psoriasis: Treatment and Pathogenesis; Immunodeficiency and Autoimmune Disorders.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Molecular HLA matching in kidney transplantation: the emerging role of eplet mismatch analysis
Simmi Mehra, Rajni Chauhan, Aseem Kumar Tiwari, Vyas M Shingatgeri et al.
2026-10-14 · DOI: 10.1080/1744666x.2026.2749714The therapeutic potential of GLP-1 receptor agonists in central nervous system diseases: immune cell modulation and neuroinflammation
Ziyu Wang, Song Xue, Xin Zhou, Mengyao Yuan et al.
2026-10-13 · DOI: 10.1080/1744666x.2026.2747225The science-to-practice gap in allergology: a critical appraisal of determinants and knowledge-translation strategies across health systems
Gabriele Di Lorenzo, Marcello Melluso, Riccardo De Carli, Aurelio Seidita et al.
2026-10-13 · DOI: 10.1080/1744666x.2026.2749713Novel understanding in diagnosis and management of exercise-induced bronchoconstriction
John W. Dickinson
2026-10-09 · DOI: 10.1080/1744666x.2026.2747863Donidalorsen for the treatment of hereditary angioedema
Samantha R. Horn, Bharosha Bhattarai, Timothy Craig
2026-10-09 · DOI: 10.1080/1744666x.2026.2747222Approaches to identify patients with rheumatoid arthritis that should be screened for interstitial lung disease
Natalie A. Davis, Madeleine Y. Beaulé, Jeffrey A. Sparks
2026-10-09 · DOI: 10.1080/1744666x.2026.2748536The mitochondria: a new culprit for lupus?
Andras Perl, Laurence Morel
2026-10-08 · DOI: 10.1080/1744666x.2026.2747220Parvovirus B19 and inflammatory arthritis: from viral mimicry to infection-associated autoimmunity
Francesco Caso, Luisa Costa, Mario Cascone, Antonio Carleo et al.
2026-10-08 · DOI: 10.1080/1744666x.2026.2746700Transient hypogammaglobulinemia of infancy: revisiting an old entity
Zehra Genç Ozbay, Saliha Esenboga
2026-10-04 · DOI: 10.1080/1744666x.2026.2742255Switchback from biosimilar tumor necrosis factor-alpha inhibitors to reference medicines: a review
Robert Moots, Sascha Gerdes, Giampiero Girolomoni, Jonas Halfvarson et al.
2026-09-02 · DOI: 10.1080/1744666x.2026.2727537Oxidative stress: a pivotal regulator of inflammation and endotypes in chronic rhinosinusitis
Xinlei Niu, Xiaozhe Yang, Haiyan Xu, Fei Gao et al.
2026-09-02 · DOI: 10.1080/1744666x.2026.2738383Follicular lymphoma and the microenvironment: potential targets and biomarkers
Zhi-Zhang Yang, Stephen M. Ansell
2026-09-02 · DOI: 10.1080/1744666x.2026.2731956SARS-CoV-2 management strategies in B-Cell-depleted people with multiple sclerosis: from prevention to antiviral treatment
Julia Feige, Larissa Hauer, Johann Sellner
2026-09-02 · DOI: 10.1080/1744666x.2026.2731966Exploring novel and evolved tools in atopic dermatitis diagnosis
Domenico Caranci, Francesco Briguori, Maddalena Spalliero, Maddalena Napolitano et al.
2026-09-02 · DOI: 10.1080/1744666x.2026.2734034Atacicept in IgA nephropathy
Sheila A. Doggrell
2026-09-02 · DOI: 10.1080/1744666x.2026.2731960The actionable exposome
Krisna C. Bhargava, Uta S. Guo, Otman Maoued, Henriett Diana Szucs et al.
2026-09-02 · DOI: 10.1080/1744666x.2026.2738409Coexisting inflammatory bowel disease and eosinophilic esophagitis: moving beyond parallel narratives to an integrated framework
Chidera Onwuzo, Cynthia Okonkwo, Gaurav Chauhan, Idan Goren et al.
2026-08-03 · DOI: 10.1080/1744666x.2026.2725811Lamotrigine and other therapy-associated HLH syndromes: a review
Yaswanta K. Gummadi, Ashley Sutherland, Steven Rowe, Luke Y.C. Chen et al.
2026-08-03 · DOI: 10.1080/1744666x.2026.2718332Direct immunofluorescence in the clinic for pemphigus and pemphigoid diseases
Hua Qian, Yuguang Zhao, Mako Mine, Xiaoguang Li et al.
2026-08-03 · DOI: 10.1080/1744666x.2026.2724860Emerging treatment strategies in systemic lupus erythematosus: integrating molecular stratification, targeted therapy, and treatment response evaluation
Yurie Satoh-Kanda, Shingo Nakayamada, Yoshiya Tanaka
2026-08-03 · DOI: 10.1080/1744666x.2026.2724853Reviews
Community Reviews
Version History
October 9, 2026 at 8:04 pm
September 25, 2026